Leye He

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

Linglong Yin, Youhong Liu, Yuchong Peng et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 127 citations · Full text

Medicine, Oncology, Pharmacology +16

The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy

Jianye Liu, Yingbo Dai, Fangjian Zhou et al. · Urologic Oncology Seminars and Original Investigations · 2016 · 84 citations

Medicine, Surgery, Urology +12

MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway

Kai Huang, Yuxin Tang, Leye He et al. · Oncology Reports · 2015 · 79 citations · Full text

Medicine, Molecular Biology, Oncology +16

Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes

Jianye Liu, Yi Zhang, Hongliang Zeng et al. · Science Advances · 2019 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Peripheral Blood Mitochondrial DNA Copy Number Is Associated with Prostate Cancer Risk and Tumor Burden

Weimin Zhou, Min Zhu, Ming Gui et al. · PLoS ONE · 2014 · 63 citations · Full text

Medicine, Genetics, Oncology +16